{
    "2020-12-02": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Top Stock Reports for Facebook, Netflix & AbbVie",
                "features": {
                    "keywords": [
                        "Facebook",
                        "Netflix",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Frontier Medicines",
                        "Global Partnership",
                        "Novel Therapies",
                        "E3 Degraders",
                        "Difficult-to-Drug Targets"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Frontier Medicines and AbbVie Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets",
                "features": {
                    "keywords": [
                        "Frontier Medicines",
                        "AbbVie",
                        "Global Partnership",
                        "Novel Therapies",
                        "E3 Degraders",
                        "Difficult-to-Drug Targets"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}